Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine versus ropivacaine serratus anterior plane block after thoracoscopic lobectomy
ChiCTR2300076281Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Oct 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of liposomal bupivacaine and ropivacaine in postoperative pain (2 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoint: Postoperative pain. Planned start Oct 2023; status: not yet recruiting.
02
Drugs
liposomal bupivacaineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300076281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076281.